ČESKÁ UROLOGIE / CZECH UROLOGY – 4 / 2020

260 PŘEHLEDOVÝ ČLÁNEK Ces Urol 2020; 24(4): 247–260 25. Kudlackova S, Kral M, Koranda P, Student V. 18-F cholin PET CT v primodiagnostice karcinomu pro‑ staty. Ces Urol 2016; 20(1): 57–64. 26. Zettinig O, Shah A, Hennersperger C, et al. Multimodal image‑guided prostate fusion biopsy based on automatic deformable registration. International Journal of Computer Assisted Radiology and Surgery 2015; 10(12): 1997–2007. 27. Storz E, Shah A, Zettinig O, et al. 217 PSMA‑PET/MRI‑guided transrectal fusion biopsy for the detection of prostate cancer. European Urology Supplements 2015; 14: e217. 28. Krimphove M, Theissen L, Cole A, et al. Performance and Impact of Prostate Specific Membrane Antigen‑Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection. The World Journal of Men’s Health 2020; 38(1): 32–47. 29. Rauscher I, Düwel C, Wirtz M, et al. Value of 111In‑prostate‑specific membrane antigen (PSMA)-radio‑ guided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow‑up. BJU International 2017; 120(1): 40–47. 30. Maurer T, Robu S, Schottelius M, et al. 99mTechnetium‑based Prostate‑specific Membrane Antigen– radioguided Surgery in Recurrent Prostate Cancer. European Urology 2019; 75(4): 659–666. 31. Zhang Q, Helfand BT, Carneiro BA, et al. Efficacy Against Human Prostate Cancer by Prostate‑specific Membrane Antigen‑specific, Transforming Growth Factor‑β Insensitive Genetically Targeted CD8+ T‑cells Derived from Patients with Metastatic Castrate‑resistant Disease. European Urology 2018; 73(5): 648–652. 32. Lamb AD, Bryant RJ, Mills IG, Hamdy FC. First Report of Prostate‑specific Membrane Antigen–targeted Immunotherapy in Prostate Cancer: The Future is Bright. European Urology 2018; 73(5): 653–655. 33. Roach PJ, Francis R, Emmett L, et al. The Impact of 68Ga‑PSMA PET/CT on Management Intent in Prostate Cancer: Results of an Australian Prospective Multicenter Study. Journal of Nuclear Medicine 2018; 59(1): 82–88. 34. Han S, Woo S, Kim YJ, Suh CH. Impact of 68Ga‑PSMA PET on the Management of Patients with Prostate Cancer: A Systematic Review and Meta‑analysis. European Urology 2018; 74(2): 179–190.